Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Distinguishing ‘Stem Cell Hype’ From Hope in Knee Osteoarthritis
• ACP: Trump’s New Insurance Rule Weakens Patient Protections
• Adults With Juvenile Idiopathic Arthritis Distinct From Those With RA
• AMA: Opioid Prescriptions Drop 22% Nationally
• CMS Releases State-Level Guidance to Fight Opioid Epidemic
• Corticosteroid, DMARD Use Increase Skin Cancer Risk in Patients With RA
• Fatigue Linked to Activity Impairment in Patients With RA, AS Starting Enbrel
• FDA Commissioner: Greater Efficiencies can Unlock Opportunities Created by Better Science
• FDA Warns 53 Websites to Stop Marketing Illegal Opioids
• More Than 70% of RA Clinic Visits Lack Discussion of Cardiovascular Risk
• Nearly 40% of Patients Fail to Initiate Prescribed RA Treatment
• Opioid Overdose, Death More Likely in Patients Who Use Multiple Prescribers, Pharmacies
• TNF Inhibitor Use During Pregnancy Not Linked to Infection Risk in Offspring
• Combination Therapy for Hypertension, Osteoarthritis Receives FDA Approval
• FDA Approves Olumiant 2 mg for RA
• FDA Expands Approval of Cimzia for Moderate-to-Severe Plaque Psoriasis
• FDA Withdraws Biosimilar Draft Guidance Following Public Comments
• Sandoz Obtains Positive CHMP Opinion for Humira Biosimilar
• FDA Approves Rituxan for Pemphigus Vulgaris
• Let’s Talk About Empathy in Rheumatology Leonard H. Calabrese, DO
• Ace the Case: A 64-Year-Old Man with Painful Knee Osteoarthritis Who Does Not Want a Total Knee Arthroplasty
• Biosimilar Barriers Persist Despite Billions in Potential Cost Savings: Who is Benefitting?
• Experts say Lawsuit Challenging Affordable Care Act Could Kill It
• Interchangeable Biologics as Safe, Efficacious as Non-Interchangeable Biosimilars
• Alternate Psoriasis Severity Index Effectively Assesses Disease Activity in Cimzia-treated PsA
• Baseline Assessment Can Predict Long-term JIA Outcomes
• Ethnicity, Hypertension Predict Gout Risk, Unexplained by Urate Level
• Fat Pad Tissue, Physiological Vascularity Added to OMERACT Ultrasound Healthy Joint Features
• Illness Perception Influences Back Pain Severity, QoL in Suspected Spondyloarthritis
• Increased Physician Supervision Does Not Reduce Medical Errors
• MPO-ANCA a Useful Predictor of ANCA-associated Vasculitis Relapse
• One-third of Arthroplasty Recipients Fail to Exercise Weekly
• One-third of Patients Switch, End DMARDs After Cardiovascular Event
• Point-of-care Uric Acid Meter Reasonably Comparable to Lab Assay
• Remission Induction Less Common With Glucocorticoid Monotherapy in IgG4-related Disease
• Sleeplessness Linked to Less Exercise in Patients With Knee OA
• Actemra, TNF Inhibitors Yield Similar Malignancy Risk in Patients With RA
• ‘Big Data’ May Bring Health Care Disruption to Rheumatology
• Disseminated Intravascular Coagulation Linked to Increased Hospital Deaths in Still’s Disease
• Favorable Pregnancy Outcomes Possible in Most Young Women With SLE
• Gout Linked to 17% Higher Risk for Dementia in Elderly
• Hospital Costs for MI Significantly Higher for Patients With PsA
• IgG4 Serum Insufficient to Diagnose IgG4-related Disease
• Joint Replacement Rates Declined More Than Half Among RA Patients
• Lupus Nephritis in First Year of SLE Predicts ‘Absolute Worst’ for Patient
• Patients With AS Have 59% Increased Risk for Deliberate Self-harm
• Questions Persist for 400% Increase in Hospitalizations Among Gout Patients
• RA Mortality Rising Despite Decline for Other Rheumatologic Diseases
• Rheumatologist, Dermatologist Collaboration Key to Identify Early PsA
• Romosozumab at Forefront of ‘Paradigm Shift’ in Osteoporosis Therapy
• Siblings of Patients With RA Share Increased Risk for Acute Coronary Syndrome
• Stem Cell Transplant, Rituxan Hold ‘Tremendous Promise’ for ILD With Systemic Sclerosis
• TNF Inhibitors May Reduce Total Hip Replacement in Older Patients With RA
• VIDEO: Cimzia Data Provide ‘Reassuring’ Pregnancy Outcomes for Rheumatic Disease, IBD
• VIDEO: Patients With RA ‘Highly Deferential’ to Rheumatologists for Treatment Escalation
• VIDEO: RNA Blood Test May Aid in Reducing Diagnostic Error for Fibromyalgia
• VIDEO: Youth Rheumatology Forum Provides ‘Key’ Venue for Trainees
• Nearly 30% of Patients With SLE Have Statin Prescription
• Chronic Diseases Account for More Than 20% of Cancer Risk
• ACR Releases Position Statement on Pharmacovigilance
• AMA Opposes CVS-Aetna Merger
• HHS: Trump’s Drug Pricing Plan Dramatically Changes Rebates, Medicare, Other Programs
• HPV Vaccine Does Not Increase Risk for Autoimmune Disease in Teen Girls
• ‘Right to Try’ May Undo Efforts on Patient Safety
• Prescription Drug Monitoring Programs Rarely Influence Prescribing Patterns in ED